摘要 |
Use of IL-31 agonists, including IL-31, are used to treat agonists are used to treat asthma, airway hyper-responsiveness or allergic rhinitis. The method comprise inhibiting, reducing, limiting or minimizing production of proimflammatory cytokines and include administration of the IL-31 agonsit during sensitization or challenge resulting in the asthma, airway hyper-responsiveness or allergic rhinitis state. |
申请人 |
ZYMOGENETICS, INC.;BILSBOROUGH, JANINE;BORT, SUSAN, J.;CHADWICK, ERIC, M.;MUDRI, SHERRI, L.;YAO, YUE;BANNINK, KENNETH, M.;MEEHAN, WOERNER, P.;REN, HONG PING |
发明人 |
BILSBOROUGH, JANINE;BORT, SUSAN, J.;CHADWICK, ERIC, M.;MUDRI, SHERRI, L.;YAO, YUE;BANNINK, KENNETH, M.;MEEHAN, WOERNER, P.;REN, HONG PING |